Patent · US Active

Compositions and methods of treating muscle atrophy and myotonic dystrophy

US11253607B2 · kind B2 · utility

7Cited by
147References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2020
Grant dateFeb 22, 2022
Priority date—
Expiry dateSep 17, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.